TrustFinance is trustworthy and accurate information you can rely on. If you are looking for financial business information, this is the place for you. All-in-One source for financial business information. Our priority is our reliability.

TrustFinance Global Insights
3월 04, 2026
2 min read
16

UBS has downgraded Syensqo shares, traded under EURONEXT:SYENS, from a Buy to a Neutral rating. The firm also significantly cut its price target for the stock to €54 from a previous target of €81, signaling a more cautious outlook.
The downgrade stems from uncertainty surrounding the earnings recovery in Syensqo’s Specialty Polymers division, which accounts for approximately 40% of the company's sales. This unit reported a 13% year-over-year drop in organic sales in its fourth-quarter results, driven by an 11% decline in volumes and increased pricing pressure.
Consequently, UBS has reduced its 2026-2028 EBITDA forecasts by an average of 13% annually and lowered EPS estimates by 27%. The analysis highlighted that the Specialty Polymers business has underperformed peers, whose volumes rose 2% while Syensqo’s fell 11% in the same quarter. The new €54 price target is based on an average of discounted cash flow and sum-of-the-parts valuations.
Although Syensqo trades at a notable 35% discount to its peers on a 2026 EV/EBITDA multiple, the persistent weakness in its key polymer segment has prompted the revised analyst rating. Future performance will likely depend on the stabilization of volumes and pricing within this critical business unit.
Q: Why did UBS downgrade Syensqo stock?
A: UBS downgraded Syensqo due to an uncertain earnings outlook for its Specialty Polymers business, which saw a significant 13% drop in organic sales.
Q: What is the new price target for Syensqo from UBS?
A: The new price target for Syensqo is €54, a sharp reduction from the previous target of €81.
Source: Investing.com

TrustFinance Global Insights
AI-assisted editorial team by TrustFinance curating reliable financial and economic news from verified global sources.
Related Articles